These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38686849)

  • 21. Theranostics of atherosclerosis by the indole molecule-templated self-assembly of probucol nanoparticles.
    Chen F; Chen J; Han C; Yang Z; Deng T; Zhao Y; Zheng T; Gan X; Yu C
    J Mater Chem B; 2021 May; 9(20):4134-4142. PubMed ID: 33972981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted nanoparticles triggered by plaque microenvironment for atherosclerosis treatment through cascade effects of reactive oxygen species scavenging and anti-inflammation.
    Luo X; Zhang M; Dai W; Xiao X; Li X; Zhu Y; Shi X; Li Z
    J Nanobiotechnology; 2024 Jul; 22(1):440. PubMed ID: 39061065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr
    Yu M; Amengual J; Menon A; Kamaly N; Zhou F; Xu X; Saw PE; Lee SJ; Si K; Ortega CA; Choi WI; Lee IH; Bdour Y; Shi J; Mahmoudi M; Jon S; Fisher EA; Farokhzad OC
    Adv Healthc Mater; 2017 Oct; 6(20):. PubMed ID: 28730752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneously Right-Side-Out-Orientated Coupling-Driven ROS-Sensitive Nanoparticles on Cell Membrane Inner Leaflet for Efficient Renovation in Vascular Endothelial Injury.
    Qin X; Zhu L; Zhong Y; Wang Y; Wu G; Qiu J; Wang G; Qu K; Zhang K; Wu W
    Adv Sci (Weinh); 2023 Feb; 10(6):e2205093. PubMed ID: 36703487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Targeting Nanotherapy for Abdominal Aortic Aneurysms.
    Cheng J; Zhang R; Li C; Tao H; Dou Y; Wang Y; Hu H; Zhang J
    J Am Coll Cardiol; 2018 Nov; 72(21):2591-2605. PubMed ID: 30466517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophage membrane coated nanoparticles: a biomimetic approach for enhanced and targeted delivery.
    Khatoon N; Zhang Z; Zhou C; Chu M
    Biomater Sci; 2022 Mar; 10(5):1193-1208. PubMed ID: 35122479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent progress in biomimetic nanomedicines based on versatile targeting strategy for atherosclerosis therapy.
    Liang L; Deng Y; Ao Z; Liao C; Tian J; Li C; Yu X
    J Drug Target; 2024 Jul; 32(6):606-623. PubMed ID: 38656224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tannic acid-poloxamer self-assembled nanoparticles for advanced atherosclerosis therapy by regulation of macrophage polarization.
    Wu H; Sheng J; Wang Z; Zu Z; Xiang K; Qi J; Wang Z; Lu G; Zhang L
    J Mater Chem B; 2024 May; 12(19):4708-4716. PubMed ID: 38654609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced breast cancer treatment using phototherapy and RNS therapy with macrophage membrane-coated liposomes.
    Wang F; Li C; Xu X; Zhang W; He Z
    Colloids Surf B Biointerfaces; 2024 Jul; 239():113961. PubMed ID: 38749169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morus alba L. (Sangzhi) alkaloids mitigate atherosclerosis by regulating M1/M2 macrophage polarization.
    Peng D; Zhuge F; Wang M; Zhang B; Zhuang Z; Zhou R; Zhang Y; Li J; Yu Z; Shi J
    Phytomedicine; 2024 Jun; 128():155526. PubMed ID: 38564921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ROS-responsive biomimetic nanoparticles for potential application in targeted anti-atherosclerosis.
    Tang D; Wang Y; Wijaya A; Liu B; Maruf A; Wang J; Xu J; Liao X; Wu W; Wang G
    Regen Biomater; 2021 Aug; 8(4):rbab033. PubMed ID: 34285811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sonodynamic therapy in atherosclerosis by curcumin nanosuspensions: Preparation design, efficacy evaluation, and mechanisms analysis.
    Jiang L; Wang J; Jiang J; Zhang C; Zhao M; Chen Z; Wang N; Hu D; Liu X; Peng H; Lian M
    Eur J Pharm Biopharm; 2020 Jan; 146():101-110. PubMed ID: 31841689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective glioblastoma immune sonodynamic treatment mediated by macrophage cell membrane cloaked biomimetic nanomedicines.
    Shan T; Wang W; Fan M; Bi J; He T; Sun Y; Zheng M; Yan D
    J Control Release; 2024 Jun; 370():866-878. PubMed ID: 38685386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extending the In Vivo Residence Time of Macrophage Membrane-Coated Nanoparticles through Genetic Modification.
    Duan Y; Zhou J; Zhou Z; Zhang E; Yu Y; Krishnan N; Silva-Ayala D; Fang RH; Griffiths A; Gao W; Zhang L
    Small; 2023 Dec; 19(52):e2305551. PubMed ID: 37635117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudolaric acid B attenuates atherosclerosis progression and inflammation by suppressing PPARγ-mediated NF-κB activation.
    Li T; Wang W; Li YX; Li X; Ji WJ; Ma YQ; Chen H; Zhao JH; Zhou X
    Int Immunopharmacol; 2018 Jun; 59():76-85. PubMed ID: 29631101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethanol extracts of Danlou tablet attenuate atherosclerosis via inhibiting inflammation and promoting lipid effluent.
    Hao D; Danbin W; Maojuan G; Chun S; Bin L; Lin Y; Yingxin S; Guanwei F; Yefei C; Qing G; Xijuan J
    Pharmacol Res; 2019 Aug; 146():104306. PubMed ID: 31181336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial dysfunction and metabolic reprogramming induce macrophage pro-inflammatory phenotype switch and atherosclerosis progression in aging.
    Vendrov AE; Lozhkin A; Hayami T; Levin J; Silveira Fernandes Chamon J; Abdel-Latif A; Runge MS; Madamanchi NR
    Front Immunol; 2024; 15():1410832. PubMed ID: 38975335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plaque-hyaluronidase-responsive high-density-lipoprotein-mimetic nanoparticles for multistage intimal-macrophage-targeted drug delivery and enhanced anti-atherosclerotic therapy.
    Zhang M; He J; Jiang C; Zhang W; Yang Y; Wang Z; Liu J
    Int J Nanomedicine; 2017; 12():533-558. PubMed ID: 28144137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. M1/M2 re-polarization of kaempferol biomimetic NPs in anti-inflammatory therapy of atherosclerosis.
    Zhao J; Ling L; Zhu W; Ying T; Yu T; Sun M; Zhu X; Du Y; Zhang L
    J Control Release; 2023 Jan; 353():1068-1083. PubMed ID: 36549391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactive Oxygen Species-Responsive Nanoparticle Delivery of Small Interfering Ribonucleic Acid Targeting Olfactory Receptor 2 for Atherosclerosis Theranostics.
    Ni H; Zhou H; Liang X; Ge Y; Chen H; Liu J; Wang B; Chen H; Zhang Y; Luo S; Chen Y; Lu X; Yin C; Fan Q
    ACS Nano; 2024 Aug; 18(34):23599-23614. PubMed ID: 39141682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.